What Is The Outlook For Russian Capital Markets?

Though small in financial terms, the news that Russia's Stem Cell Institute (SCI) is seeking to attract some RUB150mn (US$4.75mn) in an initial public offering nevertheless raises the prospect of the country's first IPO in over a year, and comes amid tentative signs of economic recovery and improved financing for Russian firms.

To read the full article, please choose one of the following options: